http://www.anaptysbio.com
AnaptysBio, Inc. Company Intro
AnaptysBio is a clinical-stage antibody development company advancing therapeutic antibody product candidates focused on unmet medical needs in inflammation.
Industry
Healthcare
AnaptysBio, Inc. Headquaters
10421 Pacific Center Court
San Diego,92121
United States
AnaptysBio, Inc. Share price
22 Oct 2020 01:05 GMT
$25.73
-0.04 (-0.16 %)
AnaptysBio, Inc. Market cap
$711.789 M
WMC RANKING
2020
AnaptysBio, Inc. # 160
BiotechnologyLatest AnaptysBio, Inc. News
21 Oct 2020
Peanut Allergy Therapeutics Market 2019 Global Industry ...
Aimmune Therapeutics Inc Alfacyte Ltd Allergy Therapeutics Plc AnaptysBio Inc ... Selecta Biosciences Inc; The research comprises products developed, ...
21 Oct 2020
Antibody Library Technologies Market Size and Status Report 2020 to 2024: Product Scope, Growth Opportunities and Revenue Estimation
Report also segmented by top vendors provides data about company ... Adimab LLC, Invenra Inc., AnaptysBio, Inc., Abwiz Bio Inc., Abgent Inc. (WuXi AppTec ...
22 Oct 2020
AnaptysBio Inc (NASDAQ:ANAB) Receives Average Rating of ...
AnaptysBio, Inc, a clinical stage biotechnology company, engages in developing antibody product candidates focused on unmet medical needs in inflammation.
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| AnaptysBio, Inc. | 0.14 | 0.59 | 0.24 | 0 | 0 | 0 | 0.63 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.15 | 100 | 19 | 0 | 0 | 98.93 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.89 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.06 | 100 | 0 | 0 | 90.93 |
AnaptysBio, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| AnaptysBio, Inc. | $8,000 | $115,432 | $-97,336 | $726.16M | 160 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $27.177B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.881B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥20.867B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.532B | 4 |